Table 2. Univariate and multivariate analyses of the associations between prognostic variables and disease-free survival or overall survival in cervical cancer.

	Disease-free Survival hazard ratio [95% CI], P value		Overall Survival hazard ratio [95% CI], P value
	Univariate analysis	Multivariate analysis	Univariate analysis	Multivariate analysis
Age	0.99 [0.97–1.02], 0.923	NA	0.98 [0.94–1.03], 0.583	NA
FIGO stage	5.32 [2.76–10.24], <0.001	1.88 [0.79–4.46], 0.153	3.27 [1.32–8.07], 0.010	3.26 [1.28–8.31], 0.013
Cell type (non-SCC)	1.15 [0.50–2.63], 0.732	NA	2.68 [1.06–6.76], 0.035	2.72 [1.06–6.98], 0.037
Tumor grade (poor)	1.98 [1.03–3.81], 0.040	1.64 [0.76–3.53], 0.207	2.40 [0.96–5.97], 0.060	NA
Tumor size (>4 cm)	2.43 [1.27–4.65], 0.007	1.93 [0.84–4.40], 0.117	1.83 [0.74–4.54], 0.188	NA
LN metastasis	4.97 [2.38–10.38], <0.001	2.57 [1.13–5.87], 0.024	2.23 [0.76–6.47], 0.141	NA
SCC Ag+	1.45 [0.71–2.96], 0.307	NA	1.80 [0.69–4.68], 0.225	NA
SCP3+	5.14 [1.82–14.52], 0.002	5.52 [1.78–17.11], 0.003	4.63 [1.07–20.01], 0.040	3.50 [0.79–15.44], 0.097
pAKT+	4.89 [1.90–12.58], 0.001	3.62 [1.19–11.05], 0.023	4.34 [1.27–14.86], 0.019	3.60 [1.04–12.42], 0.043
SCP3+/pAKT+	4.97 [2.34–10.53], <0.001	4.98 [1.90–13.01], 0.001	4.16 [1.51–11.46], 0.006	3.38 [1.21–9.43], 0.020

CI, confidence interval; FIGO, International Federation of Gynecology and Obstetrics; SCC, squamous cell carcinoma; LN, lymph node; NA, not applicable.